Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|14|8|831-839

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.14, Iss.8, 2016-11, pp. : 831-839

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunological Approaches to Prevent Neuronal Apoptosis During Neuroinflammation

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 4, 2005-08 ,pp. : 367-381

Bentham Science Publishers

Access to resources Recommend Favorite

Anthocyanins as a Potential Therapy for Diabetic Retinopathy

By  

Current Medicinal Chemistry, Vol. 22, Iss. 1, 2014-11 ,pp. : 51-58

Bentham Science Publishers

Access to resources Recommend Favorite

Neurodegeneration in the Pathogenesis of Diabetic Retinopathy: Molecular Mechanisms and Therapeutic Implications

By  

Current Medicinal Chemistry, Vol. 20, Iss. 26, 2013-09 ,pp. : 3241-3250

Bentham Science Publishers

Access to resources Recommend Favorite

Ruboxistaurin a reality for reduced vision loss in diabetic retinopathy

By  

Inpharma, Vol. 1, Iss. 1552, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Pericyte Loss in Diabetic Retinopathy: Mechanisms and Consequences

By  

Current Medicinal Chemistry, Vol. 20, Iss. 26, 2013-09 ,pp. : 3218-3225

Bentham Science Publishers

Access to resources Recommend Favorite